VF
AIM

Virtu Financial’s AIM ImmunoTech AIM Stock Holding History

Virtu Financial’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Buy
124,269
+73,374
+144% +$33.5K ﹤0.01% 1279
2026
Q1 		$30K Buy
+50,895
New +$51.6K ﹤0.01% 1354
2025
Q1 		– Sell
-367
Closed -$7K – 2249
2024
Q4 		$7K Sell
367
-655
-64% -$15.3K ﹤0.01% 1420
2024
Q3 		$28K Buy
1,022
+459
+82% +$15.3K ﹤0.01% 1094
2024
Q2 		$21K Buy
+563
New +$23.9K ﹤0.01% 1028
2024
Q1 		– Sell
-156
Closed -$7K – 2405
2023
Q4 		$7K Sell
156
-135
-46% -$6.29K ﹤0.01% 1449
2023
Q3 		$13K Buy
+291
New +$17.9K ﹤0.01% 1079
2023
Q1 		– Sell
-321
Closed -$10K – 2521
2022
Q4 		$10K Sell
321
-80
-20% -$3.72K ﹤0.01% 1393
2022
Q3 		$23K Sell
401
-148
-27% -$10.4K ﹤0.01% 1369
2022
Q2 		$43K Buy
549
+40
+8% +$3.84K ﹤0.01% 1164
2022
Q1 		$54K Buy
509
+132
+35% +$11.4K ﹤0.01% 1112
2021
Q4 		$35K Buy
+377
New +$58.3K ﹤0.01% 1420
2021
Q2 		– Sell
-295
Closed -$67K – 2439
2021
Q1 		$67K Sell
295
-744
-72% -$168K ﹤0.01% 1397
2020
Q4 		$186K Buy
1,039
+743
+251% +$149K 0.02% 887
2020
Q3 		$64K Sell
296
-370
-56% -$92.4K 0.01% 784
2020
Q2 		$165K Buy
+666
New +$162K 0.02% 767
2019
Q2 		– Sell
-15
Closed -$11K – 2129
2019
Q1 		$11K Buy
+15
New +$13.4K ﹤0.01% 1340
2018
Q3 		– Sell
-7
Closed -$10K – 2639
2018
Q2 		$10K Sell
7
-1
-13% -$1.46K ﹤0.01% 1907
2018
Q1 		$14K Sell
8
-6
-43% -$12.5K ﹤0.01% 1847
2017
Q4 		$21K Buy
14
+9
+180% +$12.9K ﹤0.01% 2219
2017
Q3 		$7K Buy
+5
New +$8.77K ﹤0.01% 2425

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Virtu Financial's AIM Position: Q2 2026 in Review

Virtu Financial increased its AIM ImmunoTech (AIM) stake by 144% in Q2 2026, buying an estimated $33.5K and bringing the position to 124,269 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Virtu Financial first reported a position in AIM in Q3 2017 and has held it in 21 quarters since. The position peaked at $186K in Q4 2020. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Virtu Financial held 124,269 shares of AIM ImmunoTech worth $35K as of Q2 2026.
  • Virtu Financial bought 73,374 AIM ImmunoTech shares in Q2 2026, an estimated $33.5K.
  • AIM ImmunoTech made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1279 holding.
  • Virtu Financial first reported a position in AIM ImmunoTech in Q3 2017 and has held it in 21 quarters since.
  • Virtu Financial's AIM ImmunoTech position peaked at $186K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.